J-INTS Bio Partners With Yuhan and Research Institutes on AI Drug Development
Translated from Korean and summarized by DistantNews. Read the original for the full story.
At a glance
News
Official statement
New plan
- J-INTS Bio, Yuhan Corp., DGIST and the Yonsei-Yuhan Lung Cancer Research Institute agreed to pursue joint AI drug-development research.
- The partners will divide work from identifying drug targets and candidates to candidate design, experimental validation and development strategy.
- J-INTS Bio is developing treatments for cancer and rare diseases and plans to use AI to identify drug candidates.
J-INTS Bio is joining forces with Yuhan Corp. and two research institutions to build an artificial intelligence-based drug-development system for cancer and rare-disease treatments.
The company signed a memorandum of understanding on the 28th with Yuhan, Daegu Gyeongbuk Institute of Science and Technology, and the Yonsei-Yuhan Lung Cancer Research Institute. The partnership will seek joint research projects related to the biotechnology industry’s adoption of AI.
The organizations will divide responsibilities across the development process. The Yonsei-Yuhan institute will identify research directions linked to patient treatment needs. DGIST will work on finding drug targets and candidate compounds, while J-INTS Bio will design the candidates and handle experimental validation and later development.
Yuhan will review development and regulatory strategies based on its experience with global drug development. The agreement also covers the commercial potential of the projects.
About this summary
Originally published by Dong-A Ilbo in Korean. Translated, summarized, and contextualized automatically by DistantNews, with a note on how the source frames the story. Not individually reviewed before publishing. How this works.
More Stories
From Our Blog
What Gets Lost (and Found) When News Is Translated
The Critical Role of Diaspora Media in Global News
What Travellers Should Know About Countries with Restricted Press
A Digital Nomad's Guide to Following Local News
How the Same Story Looks Different in Different Countries
